Risk of drug-induced liver injury from tumor necrosis factor antagonists.
Björnsson ES, Gunnarsson BI, Gröndal G, Jonasson JG, Einarsdottir R, Ludviksson BR, Gudbjörnsson B, Olafsson S.
Björnsson ES, et al. Among authors: olafsson s.
Clin Gastroenterol Hepatol. 2015 Mar;13(3):602-8. doi: 10.1016/j.cgh.2014.07.062. Epub 2014 Aug 15.
Clin Gastroenterol Hepatol. 2015.
PMID: 25131534